Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EARN
1426
Ellington Residential Mortgage REIT
EARN
$168M
| $10.3M | 0.01% |
948,000
-6,900
| -0.7% | -$75.3K |
|
|
AIMC
1427
DELISTED
Altra Industrial Motion Corp
AIMC
| $10.3M | 0.01% |
284,013
+159,504
| +128% | +$5.07M |
|
|
ESGR
1428
DELISTED
Enstar Group
ESGR
| $10.3M | 0.01% |
49,700
-17,900
| -26% | -$3.58M |
|
1429
Designer Brands
DBI
$314M
| $10.2M | 0.01% |
650,630
+541,600
| +497% | +$8.97M |
|
1430
Warner Bros
WBD
$63.9B
| $10.2M | 0.01% |
+312,350
| New | +$9.41M |
|
|
SPPI
1431
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $10.2M | 0.01% |
2,803,300
+38,283
| +1% | +$309K |
|
|
DPLO
1432
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $10.2M | 0.01% |
2,550,960
+2,346,060
| +1,145% | +$11M |
|
|
ENLC
1433
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $10.2M | 0.01% |
1,664,446
+1,552,237
| +1,383% | +$9.42M |
|
1434
iShares US Real Estate ETF
IYR
$4.69B
| $10.2M | 0.01% |
109,600
-97,600
| -47% | -$9.05M |
|
1435
Endava
DAVA
$153M
| $10.2M | 0.01% |
218,063
+76,603
| +54% | +$3.3M |
|
|
TMX
1436
DELISTED
Terminix Global Holdings, Inc.
TMX
| $10.1M | 0.01% |
261,800
-202,300
| -44% | -$8.6M |
|
1437
Viatris
VTRS
$20.7B
| $10.1M | 0.01% |
+503,100
| New | +$9.36M |
|
1438
Victory Capital Holdings
VCTR
$6.16B
| $10.1M | 0.01% |
481,995
-15,252
| -3% | -$277K |
|
|
HONE
1439
DELISTED
HarborOne Bancorp
HONE
| $10.1M | 0.01% |
919,076
+112,800
| +14% | +$1.18M |
|
1440
West Bancorporation
WTBA
$473M
| $10.1M | 0.01% |
393,752
+23,200
| +6% | +$552K |
|
|
PARA
1441
DELISTED
Paramount Global Class B
PARA
| $10.1M | 0.01% |
+240,397
| New | +$9.31M |
|
1442
Varex Imaging
VREX
$467M
| $10.1M | 0.01% |
338,400
+149,500
| +79% | +$4.47M |
|
|
NOA
1443
North American Construction
NOA
$365M
| $10.1M | 0.01% |
830,300
-210,300
| -20% | -$2.35M |
|
|
SGEN
1444
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.1M | 0.01% |
88,013
+44,400
| +102% | +$4.71M |
|
1445
Ironwood Pharmaceuticals
IRWD
$614M
| $10M | 0.01% |
753,690
+667,637
| +776% | +$7.36M |
|
1446
Consolidated Water Co
CWCO
$474M
| $10M | 0.01% |
615,184
+65,786
| +12% | +$1.09M |
|
|
KIN
1447
DELISTED
Kindred Biosciences, Inc.
KIN
| $10M | 0.01% |
1,179,298
-26,400
| -2% | -$206K |
|
1448
Vera Bradley
VRA
$99.2M
| $9.99M | 0.01% |
847,000
-303,407
| -26% | -$3.36M |
|
1449
Monarch Casino & Resort
MCRI
$2.19B
| $9.98M | 0.01% |
205,603
+7,800
| +4% | +$347K |
|
|
CAMP
1450
DELISTED
CalAmp Corp.
CAMP
| $9.98M | 0.01% |
45,274
-2,839
| -6% | -$692K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.